| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.46B | 87.62B | 87.91B | 80.55B | 75.44B | 76.40B |
| Gross Profit | 77.55B | 78.02B | 79.21B | 70.67B | 72.50B | 67.19B |
| EBITDA | 21.48B | 23.84B | 17.08B | 11.84B | 20.85B | 16.54B |
| Net Income | 15.70B | 14.72B | 9.47B | 4.83B | 10.62B | 8.01B |
Balance Sheet | ||||||
| Total Assets | 6.59T | 6.54T | 6.65T | 6.67T | 7.72T | 7.45T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 774.35B | 672.84B | 501.97B | 1.66T | 1.50T |
| Total Debt | 328.34B | 386.48B | 441.15B | 493.60B | 2.76T | 2.56T |
| Total Liabilities | 6.27T | 6.22T | 6.31T | 6.38T | 7.40T | 7.12T |
| Stockholders Equity | 327.41B | 318.52B | 338.70B | 288.07B | 309.72B | 317.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | -12.19B | -1.25T | 291.46B | 1.31T |
| Operating Cash Flow | 0.00 | 0.00 | -9.31B | -1.24T | 295.31B | 1.32T |
| Investing Cash Flow | 0.00 | 97.37B | 283.18B | 93.75B | -112.63B | -101.69B |
| Financing Cash Flow | 0.00 | -27.24B | 10.89B | -12.27B | -3.35B | -2.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥223.29B | 14.45 | ― | 2.13% | 7.77% | 5.80% | |
71 Outperform | ¥240.76B | 8.21 | 7.61% | 3.81% | 17.68% | 20.15% | |
70 Outperform | ¥200.88B | 8.55 | ― | 3.00% | 10.56% | 16.02% | |
68 Neutral | ¥240.17B | 9.68 | ― | 2.27% | 2.68% | 74.80% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ¥224.30B | 8.20 | ― | 3.46% | 11.92% | 16.40% | |
59 Neutral | ¥229.21B | 10.68 | ― | 2.55% | -0.36% | 41.38% |